Outsourcing Market Expansion

ICON plc is positioned to benefit from the expanding medical‑affairs outsourcing market, projected to reach USD 4.18 billion by 2035 with a CAGR of 7.16 % over 2026‑2035. The growth is driven by increasing clinical‑trial complexity, biologics pipelines and tighter regulatory requirements, prompting pharmaceutical companies to outsource medical writing, pharmacovigilance, regulatory affairs and clinical communication. In 2025, medical writing captured the largest share of the market at 31.45 %, while pharmacovigilance grew fastest at a CAGR of 11.55 %. Oncology dominated the therapeutic‑area segment in 2025 with 33.87 %, with neurology the fastest‑growing area at a CAGR of 10.99 %.